Scientists have identified changes in the patterns of sugar molecules that line pre-cancerous cells in the esophagus, a condition called Barrett’s dysplasia, making it much easier to detect and remove these cells before they develop into esophageal c… [...]
|
|||||||
|
You are at Home>>Cancers>>Gastric & Esophageal Cancer>> Variations in Helicobacter pylori Cytotoxin-Associated Genes and Their Influence in Progression to Gastric Cancer: Implications for Prevention. PLoS One. 2012;7(1):e29605 Authors: Rizzato C, Torres J, Plummer M, Muñoz N, Fr… [...] Prolyl hydroxylase domain 2 protein is a strong prognostic marker in human gastric cancer. Pathobiology. 2012;79(1):11-7 Authors: Kamphues C, Wittschieber D, Klauschen F, Kasajima A, Dietel M, Schmidt SC, Glanemann M, Bahra … [...] A systematic review and meta-analysis of the utility of EUS for preoperative staging for gastric cancer. Gastric Cancer. 2012 Jan 12; Authors: Cardoso R, Coburn N, Seevaratnam R, Sutradhar R, Lourenco LG, Mahar A, Law C, Yon… [...] Sequential chemotherapy with cisplatin, leucovorin, and 5-fluorouracil followed by docetaxel in previously untreated patients with metastatic gastric cancer: a phase II study. Gastric Cancer. 2012 Jan 12; Authors: Catalano V… [...] Met activation mediates resistance to lapatinib inhibition of HER2-amplified gastric cancer cells. Mol Cancer Ther. 2012 Jan 11; Authors: Chen CT, Kim H, Liska D, Gao SP, Christensen JG, Weiser MR Abstract HE… [...] |
|||||||
|
Copyright © 2012 Science Today Online - All Rights Reserved Google PR: 0 · Alexa Rank: 0 |
|||||||
Recent Comments